JPS5549594B2 - - Google Patents

Info

Publication number
JPS5549594B2
JPS5549594B2 JP12360272A JP12360272A JPS5549594B2 JP S5549594 B2 JPS5549594 B2 JP S5549594B2 JP 12360272 A JP12360272 A JP 12360272A JP 12360272 A JP12360272 A JP 12360272A JP S5549594 B2 JPS5549594 B2 JP S5549594B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP12360272A
Other languages
Japanese (ja)
Other versions
JPS4980096A (sv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP12360272A priority Critical patent/JPS5549594B2/ja
Priority to DE2359536A priority patent/DE2359536C2/de
Priority to US05/420,380 priority patent/US3936439A/en
Priority to FR7343252A priority patent/FR2209567B1/fr
Priority to CH1706973A priority patent/CH587864A5/xx
Priority to NL7316749A priority patent/NL7316749A/xx
Priority to SE7316504A priority patent/SE400295B/sv
Priority to CA187,678A priority patent/CA1012534A/en
Priority to DK663173AA priority patent/DK134490B/da
Priority to GB5678173A priority patent/GB1418120A/en
Priority to BE138648A priority patent/BE808377A/xx
Priority to HUTA1284A priority patent/HU167859B/hu
Publication of JPS4980096A publication Critical patent/JPS4980096A/ja
Priority to HK151/79A priority patent/HK15179A/xx
Publication of JPS5549594B2 publication Critical patent/JPS5549594B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP12360272A 1972-12-08 1972-12-08 Expired JPS5549594B2 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
JP12360272A JPS5549594B2 (sv) 1972-12-08 1972-12-08
DE2359536A DE2359536C2 (de) 1972-12-08 1973-11-29 2,6-Diaminonebularinderivate
US05/420,380 US3936439A (en) 1972-12-08 1973-11-30 2,6-Diaminonebularine derivatives
FR7343252A FR2209567B1 (sv) 1972-12-08 1973-12-04
CH1706973A CH587864A5 (sv) 1972-12-08 1973-12-05
NL7316749A NL7316749A (sv) 1972-12-08 1973-12-06
SE7316504A SE400295B (sv) 1972-12-08 1973-12-06 Sett att framstella nya 2,6-diaminonebularinderivat
CA187,678A CA1012534A (en) 1972-12-08 1973-12-07 2,6-diaminonebularine derivatives
DK663173AA DK134490B (da) 1972-12-08 1973-12-07 Analogifremgangsmåde til fremstilling af 2,6-diaminonebularin-derivater.
GB5678173A GB1418120A (en) 1972-12-08 1973-12-07 2,6-diaminoneburlarine derivatives
BE138648A BE808377A (en) 1972-12-08 1973-12-07 Coronary dilatory 2,6-diaminonebularine derivs - reaction of 2-halo adenosines and amine; agglomeration-inhibitory
HUTA1284A HU167859B (sv) 1972-12-08 1973-12-07
HK151/79A HK15179A (en) 1972-12-08 1979-03-22 2,6-diaminoneburlarine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12360272A JPS5549594B2 (sv) 1972-12-08 1972-12-08

Publications (2)

Publication Number Publication Date
JPS4980096A JPS4980096A (sv) 1974-08-02
JPS5549594B2 true JPS5549594B2 (sv) 1980-12-12

Family

ID=14864659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12360272A Expired JPS5549594B2 (sv) 1972-12-08 1972-12-08

Country Status (3)

Country Link
JP (1) JPS5549594B2 (sv)
BE (1) BE808377A (sv)
HK (1) HK15179A (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0477219U (sv) * 1990-11-20 1992-07-06

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5461195A (en) * 1977-10-21 1979-05-17 Takeda Chem Ind Ltd N2-substituted phenyl-2,6-diaminonebularin
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
BRPI0508488A (pt) * 2004-03-05 2007-07-31 Cambridge Biotechnology Ltd compostos terapêuticos

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0477219U (sv) * 1990-11-20 1992-07-06

Also Published As

Publication number Publication date
BE808377A (en) 1974-06-07
JPS4980096A (sv) 1974-08-02
HK15179A (en) 1979-03-30

Similar Documents

Publication Publication Date Title
CH580150A5 (sv)
CH569920A5 (sv)
BG18674A1 (sv)
BG19349A1 (sv)
AU936672A (sv)
BG19955A1 (sv)
BG20008A1 (sv)
BG20469A1 (sv)
BG20480A1 (sv)
CH1348472A4 (sv)
CH441173A4 (sv)
CH580650A5 (sv)
CH563237A5 (sv)
CH563553A5 (sv)
CH563676A5 (sv)
CH564946A5 (sv)
CH564974A5 (sv)
CH565246A5 (sv)
CH565301A5 (sv)
CH567003A5 (sv)
CH567700A5 (sv)
CH569171A5 (sv)
CH569854A5 (sv)
CH580559A5 (sv)
CH570153A5 (sv)